Cellectar Biosciences, Inc. (CLRB) Forms $1.16 Double Bottom; Pioneer Municipal High Income Advantage Trust (MAV) Sentiment Is 1.15

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Logo

Pioneer Municipal High Income Advantage Trust (MAV) investors sentiment decreased to 1.15 in 2017 Q4. It’s down -0.58, from 1.73 in 2017Q3. The ratio has worsened, as 15 institutional investors opened new and increased positions, while 13 sold and decreased their stock positions in Pioneer Municipal High Income Advantage Trust. The institutional investors in our database now have: 2.15 million shares, up from 2.14 million shares in 2017Q3. Also, the number of institutional investors holding Pioneer Municipal High Income Advantage Trust in top ten positions decreased from 1 to 0 for a decrease of 1. Sold All: 4 Reduced: 9 Increased: 7 New Position: 8.

Cellectar Biosciences, Inc. (CLRB) formed double bottom with $1.10 target or 5.00% below today’s $1.16 share price. Cellectar Biosciences, Inc. (CLRB) has $20.17M valuation. The stock increased 1.75% or $0.02 during the last trading session, reaching $1.16. About 336,313 shares traded or 47.85% up from the average. Cellectar Biosciences, Inc. (NASDAQ:CLRB) has declined 51.67% since May 3, 2017 and is downtrending. It has underperformed by 63.22% the S&P500.

Robinson Capital Management Llc holds 0.82% of its portfolio in Pioneer Municipal High Income Advantage Trust for 149,680 shares. City Of London Investment Management Co Ltd owns 272,095 shares or 0.21% of their US portfolio. Moreover, Capital Investment Advisors Llc has 0.06% invested in the company for 76,639 shares. The Minnesota-based Cliftonlarsonallen Wealth Advisors Llc has invested 0.03% in the stock. Laurion Capital Management Lp, a New York-based fund reported 397,357 shares.

The stock decreased 0.09% or $0.01 during the last trading session, reaching $10.78. About 41,349 shares traded. Pioneer Municipal High Income Advantage Trust (MAV) has declined 2.74% since May 3, 2017 and is downtrending. It has underperformed by 14.29% the S&P500.